These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6469754)

  • 21. Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.
    Adams GE; Ahmed I; Clarke ED; O'Neill P; Parrick J; Stratford IJ; Wallace RG; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Dec; 38(6):613-26. PubMed ID: 6970731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG; Russo A; Gamson J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
    Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
    Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
    Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
    J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
    Sehgal RK; Agrawal KC
    J Pharm Sci; 1982 Nov; 71(11):1203-6. PubMed ID: 7175708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
    Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M; Hall EJ; Biaglow JE; Parham JC
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
    Suto MJ; Stier MA; Werbel LM; Arundel-Suto CM; Leopold WR; Elliott WE; Sebolt-Leopold JS
    J Med Chem; 1991 Aug; 34(8):2484-8. PubMed ID: 1875345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R; Workman P; Owen L
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
    Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H
    Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitization of hypoxic mammalian cells in vitro by some 5-substituted-4-nitroimidazoles.
    Adams GE; Fielden EM; Hardy C; Millar BC; Stratford IJ; Williamson C
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Aug; 40(2):153-61. PubMed ID: 6974144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosensitization of Chinese hamster cells by pimonidazole (Ro 03-8799) at low X-ray doses.
    Watts ME; Woodcock M
    Br J Radiol; 1991 Oct; 64(766):971-4. PubMed ID: 1954543
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
    Papadopoulou MV; Bloomer WD
    Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization.
    Jette DC; Wiebe LI; Flanagan RJ; Lee J; Chapman JD
    Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
    Michaels HB
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I.
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 1997; 9(5):249-57. PubMed ID: 9306432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.